DOCSLIB.ORG

Flwsffiffi Thutr0tri*Rhtnilsf Rutgts'

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Flwsffiffi Thutr0tri*Rhtnilsf Rutgts' flWsffiffi tHutR0trI*rHTnilsf Rutgts' APPENDIX 10: DetailedList of DEA Controlled SubstancesSchedules I-V. Schedule I i i iDEAlNoni : Substance l-.--:- ;-.''"-.. i OtherNames l\umDer l\arcouc l -.i- - --.-...- - --t....-... ..t -rheny] 17458 I ;(t gyclohexyl)pyn9]1ling N ieCey,PHP. rolicyclidine I -(2-Phenylethyl)-4-phenyl-4- 9663 PEPAP,syrthetic heroin 1 -u-.-g,t,ollpip-"_1i-:x*- ._ l'---..'* 1-tl-(2- 17470 iN ITCP,tenocyclidine Thienyl)cyclohexyllpiperidine -1**-1 : 1-[1-(2- :7473 IN ITCPY rhigrtyl)cy91on9;yllg-rnolale , , a .-*"J"- I l-Methyl-4-phenyl-4- :e66r L MPPP.svnthetic heroin propionoxypiperidine a I 2,5-Dimethoxy-4- 7399 N JDOET 1 ethylamphetamine j 2,5-Dimethoxyamphetamine .7396 N |DMA,2,5-DMA 3,4,5 -Trimethoxyamphetamtne a7390 t )>v ,Nl1\ iTMAI llvln 3,4-Methylenedi oxyamphetamine iN rMDA, Love Drug 17400 .,.. ,,,...... .,-! f4oi lN j tr,tDtr,fA,Ecstasy, XTC t Methylenedioxymethamphetamine 3,4-Methylenedioxy-N- 17404 LN MDA, MDE,MDEA I t lN-eavt :tr/l-p_.1*ery::- | "_ ..J................... , i98r3 I ---' );MethVlfen.tan;1y_1 - 1" " 3-Methlly:"o_l:::yy1 :9833 1 _, t"."" 4-Bromo-2,5- t7391 iN h"1m: i l, - ',t .$1.1_rehox,vamp_ ** 1--**',*"'" "('-'' ' 4-Bromo-2,5- 17392 ;N jNexus,2-CB, has been sold as Ecstasy, l1 -9i.T..ho'vp-l-:l:Pl?--i": i .. ..*..... -:....- ii:e-YP-Y4- 4-Methoxyamphetamine nqn lN LPMA 4-Methyl-2,5- ;7395 DOM, STP t ;N dimethoxyamphetamine 4-Mclhy-la-mipg;ex(c11]-sorner) il;eo N !YiP\:w:d:an- 5-Methoxy-3,4- i740r N ;MMDA enediox yamphetamine _methyl Acetorlhlng io?la *4_9_:ilr-3_1p._[a-m:r.1]J-ll:'i**9815 eg9yr_{lllyaroco-$eine 905r l Acetylcodone Acetylmethadol Methadyl acetate i?9::o! --1 Allylprodine igaoz HouseholdHazardous Waste CollectionsGuidelines 35 September2008 Revision12 ffiwrs&c s s ;'%" rt{tfIRililmr ilTA[ snnilc[s" APPENDIX 10: DetailedList of DEA Controlled SubstancesSchedules I-V (page2 otTl) Alphacetylmethadolexcept levo- alphacetylmethadol A lpha-Ethyltryptamine Alphamepro_dine Alphamethadol Alpha-Methylfentanyl i9814 . lr*-_**__"::__* Alpha-Methylthiofentanyl :9832 Aminorex 1585 N hasbeen sold as methamphetamine e."{-..gg"; ::_ _ _:::t'"ot' '9052 l Benzvlmorohine -*-**^***.i l ngsgetyJge*39:l. 9607 I r .P,-.:.1?:H-v9p*y-:3-.i-lllfentanyl 983l Cni".wr,ii.. fentanyl Beta-Hydroxyfentanyl 9830 jChina White, fentanyl Betameprodin 9608 _ _- - P:i3t-l-ffi. ?6i1 j 1 Bufotenine :7433 iN iMappine,N,N-dimethylserotonin Cathinonel235NConstituentof''Klrat''p|ant ; -i Codeinemethylbromide 19070 I I r Codeine-N-oxide jSOS: t t*** 9ryrygpli,: ".".._- 1e054190s4 . Diampromide 961s Diethylthiambutene ::.,,.,.,,.,.......,9676., ,7434 N .DET 9-*il-vl5vp-l-rsl" 'f*..__- Difenoxin r9168 Dihydromorphine 9145 Dimenoxadol 9617 Dimepheptanol 9618 Dimethylthiambutene 9619 I 'r'l DiT.9lnylffypta.line_ r7435:N ]DMT -:l-------!--*" Dlo*ry|:j/ butyrale l* -lgiGii.9621 :-: Dipipanone rDipipan, phenylpiperone HCl, Diconal, 1: ,Wg]lconal HouseholdHazardous Waste Collections Guidelines 36 September2008 Revisionl2 ds* s s ;a%* LffSgffiffiWtrffirltwn0fi!il[ BTAIsr Rvlerso APPENDIX 10: DetailedList of DEA ControlledSubstances Schedules I-V (page3 of 11) ""r""" ^ """"";---'a-'"" Drotebanol 193351 iMetebanyl,ox)'rnethebanol Ejhv.lmethvlthl"-byj:i-. Etonitazene Etorphine(except HCI) 9056 I I Etgxerijle 262s'---'--:t-* l--'-*..a Fenethylline jtSO: :N iCaptagon,amfetyline,ethyltheophylline 1 amphetamine Furethidine 19626 l" GamaHydroxybutyic Acid (GHB) 12010lN IGHB,gamahydroxybutlrate, sodium i oxybate He_r,oin lszoo IDiacetylmorphine, diamorphine -"1-**' Hyfromorphi ;9301 Hydroxypethidine *+.*.^---.-isezt ]bgsalle -- :7260 Ketobemidone 9628 -f-- "- --- Levomoramid -t*^"-*-*.:e62e Levophenacylmorphan !ry::c'"-gd9ffiyJ*l: ]z:rs iN ilSD,lysergid" I Marijuana 17360N Cannabis,marijuana i -:**-***^'r-*-1*-:11t3-iN"...."..".--.t-.^ ^-t^^.- Mecloqualone iNutu.""" - Mescaline itt8flN lC;;;ii#;or"Peyote"cacti : Methaqualone 12565iN Quaalude,Parest, Somnafac, Opitimil, r Mandrax Methcathinone 11237lN N-Methylcathinone,"cat" Methyldesorphine Methyldihydromorphine 19304i I Morpheridine 9632i i i I Morphine methylbromide 9305 Morphinemethylsulfonate e306i '19307 Morphine-N-oxide , ) -i%;8": ' Myrophine -i:l;80'N- N,N-Dimethylamphetamine N;Ethyl; 1-ph eny] cyclohexylamine ;PCE lttit iNt - - ***-.- N-Ethyl-3-piperidyl benzilate :tt8t-lNiIB323 N-Ethylamphetamine jN N-Hydroxy-3,4- iz+oz 1N-hydroxyMDA methylenedi oxyamphetamine !:, HouseholdHazardous Waste Collections Guidelines 37 September2008 Revision12 Mffi.stRulf rfiun0HHEllTAl Esf APPENDIX 10: DetailedList of DEA Controlled SubstancesSchedules I-V (page4 of 11) \11o_:"99"i"" 9309 ',9312 Nicomorphine ,Vilan -- - f : i'------- N:-M"t-h-Yl-;1-;P,ll9'd/9:--l::1f i7484rN rJB336 Noracymethadol 9633 :9614' N_or.]gv_grlianol i'-- . ! l" " " '"-r-"'*l- Iv:::J-h*-9::":" :9635 t ;Phenyldimazone Ngrmo1phfne 9313 NgglPSlon' i9636 Pa_ra-Fluorofentanyl 9812 ChinaWhite, fentanyl Parahexyl :N I Synhexyl, i -i . .....................t I Peyote 1N ;Cactus which contains mescaline 1 -,i...","...... .. " Phenadoxone l lh:lgrp'-o-19' lh::9T-9'pl9'- Phenoperidine :9641: :Operidine,Lealgin Pholcodine ,93t4 ,Copholco, Adaphol, Codisol, Lantuss, iPholcolin Piritramide 9642 Piridolan Proheptazine 9643 "l-:9r-"11']"" !*:,p::?.^ " Psilocybin Psilocyn i7438 N rPsilocin,constituent of "Magic l mushrooms" --),.........---:i* -a^ *"^ ""- - - "1 Racemoramide 9645 i j Tetrahydrocannabinol s :7370jN ]THC, Delta-8THC, Delta-gTHC and : i :others Thebacon 9315 i iAcetylhydrocodone,Acedicon,Thebacetyl Thiofentanyl 9835 l ,Chine white, fentanyl Tilidine 9750 'Tilidate,Valoron, Kitadol, Lak, Tilsa Trimeperidine 9646 t ;Promedolum Schedule II -Phenylcyc19f 1exyl i7460 N ;PrecusorofPCP i 3*o : I -Piperidinocyclohexanecarbonitrile r8603:N ,PCC,precusor of PCP Aht1ril -- --* *""imill*T;;;;il:9737i :Alfenta Alphaprodine HouseholdHazardous Waste Collections Guidelines September2008 Revisionl2 ffiffiMffirH$R0tImrHT&srnucts& APPENDIX 10: DetailedList of DEA Controlled SubstancesSchedules I-V (page5 of 11) Amobarbital 2125rN Amytal,Tuinal Arnghejamine i1100iN jDexedrine,Biphetamine Anileridine gO2O Leritine Benzoylecgonine er80 C;;il;;"borite Bezitramide 9800I lBurgodin Coca Leaves 9-04, , I --Tzll ' 'eropo*yprr.n. it fnon-aorug, :l Dipl:nol4*"--- _ 1rtzo, l -. P:p:-*:9'p.!:::.- " ""i?9:"-""""T- 1 fljgrdim*eHC1 lsossi iM 99 j 19801 Jlnnovar,Sublimaze,Duragesic l92t1nyt ! Gr**Ts:9' i2550 iN lDoriden,Dorimide I Hydrocodone 9193 t, ;dihydrocodeinone iszzat jlsoamidone i:9***s""""- !-" .-,- . *-,..r, -*^i*--* Levo-alphacetylmethadol :9648 t 1LAAM, long actingmethadone, ; : llevomethadylacetate t-evom.ej!9.ry..|g Levorphanol , r'*---- !:-- -';" "' M"p"rl9-Tr*- i9230 : lDemerol, Mepergan,- pethidine M":p-.:1d1"-.",11term3diale_;N precursor lMeperidine -****,j 1 Meperidineintermediate-B lMeperidineprecursor 1 :923"?":ti-^' ' Meperidine precursor -$7erid-iy;_;nt-grmedrat:1Q- - *'|-"':iszs+ .1 1 Metazocine :9240t Methadone iSZSO: iDolophine,Methadose, Amidone i'-------,- i Methadone intermediate i9254 :, iMethadoneprecursor Methamphetamine 1105iN iDesoxyn,D-desoxyephedrine, ICE, Crank, tSpeed Methylphenidate 1724tN lrututin HouseholdHazardous Waste Collections Guidelines 39 September2008 Revision 12 Mffirffi TT{IIIR{IfiMTHTfiT SERUMTSP APPENDIXl0: DetailedList of DEA ControlledSubstances Schedules I-V (page6 of 11) Metopon 1e26oii Moramide-intermediate i;;;;-i:^1*iewzii Morphine 19300i iMS Contin, Roxanol,Duramorph, RMS, I i ;MSIR Nabilone iN :Cesamet - 17379' ..'a f-- ""';'"-'- opiuJ""r.u",t i9610i i 1:i 'i* " " Opium fluid extracl :96)O -"-'1-----"-- !* o,pr:T-PgPPI* ;9650: lPapaversomniferum --^?*--'-;---'i"' ----J I Opium tincture 19630I llaudanum i Opium, granulated 19640i iGranulatedopium I Opium, powdered i9639| lPowderedOpium r l-)nirrm rorrr 9600 Rawopium, gum opium Oxycodone 19143'1 JOxyContin,Percocet, Tylox, Roxicodone, i ! lRoxicet, Oxymorp-hone :Numorphan ,9652 Pentobarbital ;2270'NrNembutal : ***i-**":....*.r* '..*--l Ph3,naz21ltry., l7ltSl lNarphen,Prinadol : Phencyclidine i7471lN IPCP,Semylan Phenmetrazine 1631N Preludin Phenylacetone :8501jN 1P2P,phenyl-2-propanone, benzyl methyl : i lketone Piminodine e73oI i :concentra l-oppvsn?y-,c-?:-l?li-* ::-970: 1 Secobarbital Z:tS ]N lseconal,Tuinal i '1 rh:bti-l:- *:11?j ,-rP' ScheduteIII : Amobarbital& noncontrolledactive ingred. 2126 lN lAmobarbitaVephedrinecapsules I Amobarbitalsuppository dosage form irio N Anabolic steroids 4000 N "Bodv Buildins" druss g!$ysleroia'- _.-"*_- ",;"4900_?:91Bllldi"e'l&lg: _ j2100 Barbituricacid derivative lN lBarbituratesnot specificallylisted HouseholdHazardous Waste Collections Guidelines 40 September2008 Revisionl2 ffiMffirffi uH$m0nHrflTsts[RUtf Ef,p APPENDIX l0: DetailedList of DEA ControlledSubstances Schedules I-V (page7 of 11) Benzphetamine 1228:N Didrex,Inapetyl Boldenone 4000 N jEquipoise,Parenabol, Vebonol, ; idehydrotestosterone B:"p-:-g::-ti:i 9064: ]Buprenex,Temgesic i __: ...............:.................. .:..... .. Butabarbital 2100lN iButisol,Butibel Py*rbtt" 2100lN !Fiorinal,Butalbital with aspirin Chlorhexadol 2510iN jMechloral,Mecoral, Medodorm, Chlorotestosterone(same as clostebol) Chlorphentermin-q 1645 Dil"l':l*-:: ,!"9:t* AP-:.:-*:D-: Clorterm_rne 1647iN lVoranil Clostebol 14000lN lAlfa-Trofodermin,Clostene, 4- l 1 : ]chlorotestosterone I -----,r,***i*j* I alkalgid mg{u j9803 papaverine cgdeine& 199curnoli1e e! j iCodeine with or noscapine Codeinecombination product 90 mg/du i9804I lEmpirin,Fiorinal, Tylenol, ASA or APAP i 1 w/codeine D-ehy_drochl ormgt!-yl19:lg:1".-ot -g......-.........- 4000iN Oral-Turinabol
Load more

Recommended publications
  • Backing Material Packaging Liner
    US009314527B2 (12) United States Patent (10) Patent No.: US 9,314,527 B2 Cottrell et al. (45) Date of Patent: *Apr. 19, 2016 (54) TRANSDERMAL DELIVERY PATCH 9/7061 (2013.01); A61K 9/7084 (2013.01); (71) Applicant: Phosphagenics Limited, Clayton, A61 K3I/355 (2013.01); A61K47/24 Victoria (AU) SE7 8E.O. (72) Inventors: Jeremy Cottrell, Caulfield South (AU); ( .01): ( .01): (2013.01) Giacinto Gaetano, South Melbourne (AU); Mahmoud El-Tamimy, Meadow (58) Field of Classification Search Heights (AU); Nicholas Kennedy, None Boronia (AU); Paul David Gavin, See application file for complete search history. Chadstone (AU) (56) References Cited (73) Assignee: Phosphagenics Limited, Victoria (AU) (*) Notice: Subject to any disclaimer, the term of this U.S. PATENT DOCUMENTS patent is extended or adjusted under 35 2,407,823. A 9, 1946 Fieser U.S.C. 154(b) by 0 days. 2.457,932 A 1/1949 Solmssen et al. This patent is Subject to a terminal dis- (Continued) claimer. (21) Appl. No.: 14/550,514 FOREIGN PATENT DOCUMENTS ppl. No.: 9 (22) Filed: Nov. 21, 2014 A 3.3 5.83 (65) Prior Publication Data (Continued) Related U.S. Application Data Gianello et al. Subchronic Oral Toxicity Study of Mixed Tocopheryl (63) Continuation of application No. 14/086,738, filed on Phosphates in Rates, International Journal of Toxicology, 26:475 Nov. 21, 2013, now abandoned, which is a 490; 2007.* continuation of application No. 13/501,500, filed as (Continued) application No. PCT/AU2011/000358 on Mar. 30, 2011, now Pat. No. 8,652,511. Primary Examiner — Robert A Wax (60) Provisional application No.
    [Show full text]
  • 2019 Complete Law Book
    Message from the Board Chairman Welcome to the Gem State! Thank you for downloading the Idaho Pharmacy Law Book, which compiles select state laws relevant to the practice of pharmacy in or into Idaho. The Board acknowledges that changes in the education and training of pharmacists, as well as rapid advancements in the technology environment, have required a change in approach to regulating the practice of pharmacy. The Board continues to embrace those changes and the growth of our profession. Rule 27.01.01.100 provides guidance to licensees and registrants as they determine whether a specific act is permissible. First, a licensee or registrant should consider whether the act is expressly prohibited by any state or federal law. If an act is not expressly prohibited, the licensee should consider whether: • The act is consistent with the licensee or registrant’s education, training or practice experience; and • Performance of the act is within the accepted standard of care that would be provided in a similar setting by a reasonable and prudent licensee or registrant with similar education, training and experience. Two questions that may help licensee or registrant’s successfully navigate this change in approach from prescriptive rules to professional judgment follow: 1. If someone asks why I made this decision, can I justify it as being consistent with good patient care and with law? 2. Would this decision withstand a test of reasonableness (e.g., would another prudent pharmacist make the same decision in this situation)? You should consult an attorney if you have questions as to the legality of your actions under the laws and rules regulating pharmacy in the State of Idaho.
    [Show full text]
  • CONTROLLED SUBSTANCE, DRUG, DEVICE and COSMETIC ACT - SCHEDULE I CONTROLLED SUBSTANCES Act of Jun
    CONTROLLED SUBSTANCE, DRUG, DEVICE AND COSMETIC ACT - SCHEDULE I CONTROLLED SUBSTANCES Act of Jun. 23, 2011, P.L. 36, No. 7 Cl. 35 Session of 2011 No. 2011-7 SB 1006 AN ACT Amending the act of April 14, 1972 (P.L.233, No.64), entitled "An act relating to the manufacture, sale and possession of controlled substances, other drugs, devices and cosmetics; conferring powers on the courts and the secretary and Department of Health, and a newly created Pennsylvania Drug, Device and Cosmetic Board; establishing schedules of controlled substances; providing penalties; requiring registration of persons engaged in the drug trade and for the revocation or suspension of certain licenses and registrations; and repealing an act," further providing for Schedule I controlled substances. The General Assembly of the Commonwealth of Pennsylvania hereby enacts as follows: Section 1. Section 4(1) of the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, amended November 24, 1999 (P.L.894, No.55), is amended to read: Section 4. Schedules of Controlled Substances.--The following schedules include the controlled substances listed or to be listed by whatever official name, common or usual name, chemical name, or trade name designated. (1) Schedule I--In determining that a substance comes within this schedule, the secretary shall find: a high potential for abuse, no currently accepted medical use in the United States, and a lack of accepted safety for use under medical supervision. The following controlled substances are included in this schedule: (i) Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, unless specifically excepted, whenever the existence of such isomers, esters, ethers and salts is possible within the specific chemical designation: 1.
    [Show full text]
  • Control Substance List
    Drugs DrugID SubstanceName DEANumbScheNarco OtherNames 1 1-(1-Phenylcyclohexyl)pyrrolidine 7458 I N PCPy, PHP, rolicyclidine 2 1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine 9663 I Y PEPAP, synthetic heroin 3 1-[1-(2-Thienyl)cyclohexyl]piperidine 7470 I N TCP, tenocyclidine 4 1-[1-(2-Thienyl)cyclohexyl]pyrrolidine 7473 I N TCPy 5 13Beta-ethyl-17beta-hydroxygon-4-en-3-one 4000 III N 6 17Alpha-methyl-3alpha,17beta-dihydroxy-5alpha-androstane 4000 III N 7 17Alpha-methyl-3beta,17beta-dihydroxy-5alpha-androstane 4000 III N 8 17Alpha-methyl-3beta,17beta-dihydroxyandrost-4-ene 4000 III N 9 17Alpha-methyl-4-hydroxynandrolone (17alpha-methyl-4-hyd 4000 III N 10 17Alpha-methyl-delta1-dihydrotestosterone (17beta-hydroxy- 4000 III N 17-Alpha-methyl-1-testosterone 11 19-Nor-4-androstenediol (3beta,17beta-dihydroxyestr-4-ene; 4000 III N 12 19-Nor-4-androstenedione (estr-4-en-3,17-dione) 4000 III N 13 19-Nor-5-androstenediol (3beta,17beta-dihydroxyestr-5-ene; 4000 III N 14 19-Nor-5-androstenedione (estr-5-en-3,17-dione) 4000 III N 15 1-Androstenediol (3beta,17beta-dihydroxy-5alpha-androst-1- 4000 III N 16 1-Androstenedione (5alpha-androst-1-en-3,17-dione) 4000 III N 17 1-Methyl-4-phenyl-4-propionoxypiperidine 9661 I Y MPPP, synthetic heroin 18 1-Phenylcyclohexylamine 7460 II N PCP precursor 19 1-Piperidinocyclohexanecarbonitrile 8603 II N PCC, PCP precursor 20 2,5-Dimethoxy-4-(n)-propylthiophenethylamine 7348 I N 2C-T-7 21 2,5-Dimethoxy-4-ethylamphetamine 7399 I N DOET 22 2,5-Dimethoxyamphetamine 7396 I N DMA, 2,5-DMA 23 3,4,5-Trimethoxyamphetamine
    [Show full text]
  • Drugs of Abuseon September Archived 13-10048 No
    U.S. DEPARTMENT OF JUSTICE DRUG ENFORCEMENT ADMINISTRATION WWW.DEA.GOV 9, 2014 on September archived 13-10048 No. v. Stewart, in U.S. cited Drugs of2011 Abuse EDITION A DEA RESOURCE GUIDE V. Narcotics WHAT ARE NARCOTICS? Also known as “opioids,” the term "narcotic" comes from the Greek word for “stupor” and originally referred to a variety of substances that dulled the senses and relieved pain. Though some people still refer to all drugs as “narcot- ics,” today “narcotic” refers to opium, opium derivatives, and their semi-synthetic substitutes. A more current term for these drugs, with less uncertainty regarding its meaning, is “opioid.” Examples include the illicit drug heroin and pharmaceutical drugs like OxyContin®, Vicodin®, codeine, morphine, methadone and fentanyl. WHAT IS THEIR ORIGIN? The poppy papaver somniferum is the source for all natural opioids, whereas synthetic opioids are made entirely in a lab and include meperidine, fentanyl, and methadone. Semi-synthetic opioids are synthesized from naturally occurring opium products, such as morphine and codeine, and include heroin, oxycodone, hydrocodone, and hydromorphone. Teens can obtain narcotics from friends, family members, medicine cabinets, pharmacies, nursing 2014 homes, hospitals, hospices, doctors, and the Internet. 9, on September archived 13-10048 No. v. Stewart, in U.S. cited What are common street names? Street names for various narcotics/opioids include: ➔ Hillbilly Heroin, Lean or Purple Drank, OC, Ox, Oxy, Oxycotton, Sippin Syrup What are their forms? Narcotics/opioids come in various forms including: ➔ T ablets, capsules, skin patches, powder, chunks in varying colors (from white to shades of brown and black), liquid form for oral use and injection, syrups, suppositories, lollipops How are they abused? ➔ Narcotics/opioids can be swallowed, smoked, sniffed, or injected.
    [Show full text]
  • Advisory Council on the Misuse of Drugs Chair: Professor Les Iversen Secretary: Rachel Fowler 3Rd Floor Seacole Building 2
    ACMD Advisory Council on the Misuse of Drugs Chair: Professor Les Iversen Secretary: Rachel Fowler 3rd Floor Seacole Building 2. Marsham Street London SW1P 4DF 020 7035 0454 Email: [email protected] Rt Hon. Theresa May MP Home Office 2 Marsham Street London SW1P 4DF 18th October 2012 Dear Home Secretary, In March 2012 the ACMD advised that methoxetamine be subject to a temporary class drug order. Methoxetamine was marketed as a legal alternative to ketamine until a temporary class drug order was implemented in April 2012. As is now required, the ACMD has followed its initial assessment with a consideration of methoxetamine in the context of the Misuse of Drugs Act 1971; I enclose the report with this letter. The chemical structure of methoxetamine bears a close resemblance to that of both ketamine and phencyclidine (PCP, „Angel Dust‟, a class A drug), which both produce well- documented and serious adverse effects following both acute and chronic usage. Users report that the effects of methoxetamine are similar to those of ketamine, however, some users report that the effects are of longer duration.The harmful effects reported include severe dissociation, cardiovascular symptoms, paranoid thoughts and unpleasant hallucinations. The first analytically confirmed series reported by Guy‟s and St Thomas‟ NHS Foundation Trust, London in 2011, was of three individuals who presented having self-reported use of methoxetamine. All three presented with a ketamine-like dissociative state, but also had significant stimulant effects with agitation and cardiovascular effects including tachycardia and hypertension. Toxicological screening of serum samples confirmed methoxetamine use in two of the cases.
    [Show full text]
  • Introduced B.,Byhansen, 16
    LB301 LB301 2021 2021 LEGISLATURE OF NEBRASKA ONE HUNDRED SEVENTH LEGISLATURE FIRST SESSION LEGISLATIVE BILL 301 Introduced by Hansen, B., 16. Read first time January 12, 2021 Committee: Judiciary 1 A BILL FOR AN ACT relating to the Uniform Controlled Substances Act; to 2 amend sections 28-401, 28-405, and 28-416, Revised Statutes 3 Cumulative Supplement, 2020; to redefine terms; to change drug 4 schedules and adopt federal drug provisions; to change a penalty 5 provision; and to repeal the original sections. 6 Be it enacted by the people of the State of Nebraska, -1- LB301 LB301 2021 2021 1 Section 1. Section 28-401, Revised Statutes Cumulative Supplement, 2 2020, is amended to read: 3 28-401 As used in the Uniform Controlled Substances Act, unless the 4 context otherwise requires: 5 (1) Administer means to directly apply a controlled substance by 6 injection, inhalation, ingestion, or any other means to the body of a 7 patient or research subject; 8 (2) Agent means an authorized person who acts on behalf of or at the 9 direction of another person but does not include a common or contract 10 carrier, public warehouse keeper, or employee of a carrier or warehouse 11 keeper; 12 (3) Administration means the Drug Enforcement Administration of the 13 United States Department of Justice; 14 (4) Controlled substance means a drug, biological, substance, or 15 immediate precursor in Schedules I through V of section 28-405. 16 Controlled substance does not include distilled spirits, wine, malt 17 beverages, tobacco, hemp, or any nonnarcotic substance if such substance 18 may, under the Federal Food, Drug, and Cosmetic Act, 21 U.S.C.
    [Show full text]
  • Designer Drugs: a Review
    WORLD JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES Chavan et al. World Journal of Pharmacy and Pharmaceutical Sciences SJIF Impact Factor 5.210 Volume 4, Issue 08, 297-336. Review Article ISSN 2278 – 4357 DESIGNER DRUGS: A REVIEW Dr. Suyash Chavan,MBBS*1 and Dr. Vandana Roy2 1MD, Resident Doctor, Department of Pharmacology, Maulana Azad Medical College, New Delhi. 2MD, PhD Professor, Department of Pharmacology, Maulana Azad Medical College, New Delhi. ABSTRACT Article Received on 25 May 2015, Designer drugs‟ are psychoactive substances that mimic the effects of Revised on 16 June 2015, other banned illicit drugs but evade detection by law enforcing Accepted on 07 July 2015 agencies. This is because of modifications in the structure of the original psychoactive molecule. Originally developed as a way to *Correspondence for evade existing drug laws in the late 1960s, the synthesis and use of Author designer drugs has increased dramatically. They are advertised with Dr. Suyash Chavan innocuous names and are sold mostly over the internet, discreet outlets MD, Resident Doctor, Department of and at entertainment clubs. Victims may exhibit symptoms similar to Pharmacology, Maulana the effects of the illegal drug that these synthetic drugs mimic, Azad Medical College, however, the exact culprit drug is not detected due to structural New Delhi. modifications in the new drug. Overdose of these drugs may lead to serious adverse effects that can be life threatening. Understanding the pharmacology and toxicology of these agents is essential to facilitate their detection and to provide better medical care for patients suffering from adverse effects due to their consumption.
    [Show full text]
  • 16.19.20 Nmac 1 Title 16 Occupational And
    TITLE 16 OCCUPATIONAL AND PROFESSIONAL LICENSING CHAPTER 19 PHARMACISTS PART 20 CONTROLLED SUBSTANCES 16.19.20.1 ISSUING AGENCY: Regulation and Licensing Department - Board of Pharmacy. [16.19.20.1 NMAC - Rp 16.19.20.1 NMAC, 06-26-2018] 16.19.20.2 SCOPE: All persons or entities that manufacture, distribute, dispense, administer, prescribe, deliver, analyze, or conduct research using controlled substances. [16.19.20.2 NMAC - Rp 16.19.20.2 NMAC, 06-26-2018] 16.19.20.3 STATUTORY AUTHORITY: Section 30-31-11 of the Controlled Substances Act, 30-31-1 through 30-31-42 NMSA 1978, authorizes the board of pharmacy to promulgate regulations and charge reasonable fees for the registration and control of the manufacture, distribution and dispensing of controlled substances. [16.19.20.3 NMAC - Rp 16.19.20.3 NMAC, 06-26-2018] 16.19.20.4 DURATION: Permanent. [16.19.20.4 NMAC - Rp 16.19.20.4 NMAC, 06-26-2018] 16.19.20.5 EFFECTIVE DATE: June 26, 2018, unless a different date is cited at the end of a section. [16.19.20.5 NMAC - Rp 16.19.20.5 NMAC, 06-26-2018] 16.19.20.6 OBJECTIVE: The objective of Part 20 of Chapter 19 is to protect the public health and welfare of the citizens of New Mexico by controlling and monitoring access to controlled substances and to give notice of the board’s designation of particular substances as controlled substances. [16.19.20.6 NMAC - Rp 16.19.20.6 NMAC, 06-26-2018] 16.19.20.7 DEFINITIONS: [RESERVED] [16.19.20.7 NMAC - Rp 16.19.20.7 NMAC, 06-26-2018] 16.19.20.8 REGISTRATION REQUIREMENTS: Persons required to register: A.
    [Show full text]
  • Chapter 329 [New] Uniform Controlled Substances Act
    CHAPTER 329 [NEW] UNIFORM CONTROLLED SUBSTANCES ACT Part I. General Provisions Section 329-1 Definitions 329-2 Hawaii advisory commission on drug abuse and controlled substances; number; appointment 329-3 Annual report 329-4 Duties of the commission Part II. Standards and Schedules 329-11 Authority to schedule controlled substances 329-12 Nomenclature 329-13 Schedule I tests 329-14 Schedule I 329-15 Schedule II tests 329-16 Schedule II 329-17 Schedule III Tests 329-18 Schedule III 329-19 Schedule IV tests 329-20 Schedule IV 329-21 Schedule V tests 329-22 Schedule V 329-23 Republishing and distribution of schedules Part III. Regulation of Manufacture, Distribution, Prescription, and Dispensing of Controlled Substances 329-31 Rules 329-31.5 Clinics 329-32 Registration requirements 329-33 Registration 329-34 Revocation and suspension of registration 329-35 Order to show cause 329-36 Records of registrants 329-37 Filing requirements 329-38 Prescriptions 329-39 Labels 329-40 Methadone treatment programs Part IV. Offenses and Penalties 329-41 Prohibited acts B-penalties 329-42 Prohibited acts C-penalties 329-43 Penalties under other laws 329-43.5 Prohibited acts related to drug paraphernalia Amended 0612 1 329-44 Notice of conviction to be sent to licensing board, department of commerce and consumer affairs 329-45 Repealed 329-46 Prohibited acts related to visits to more than one practitioner to obtain controlled substance prescriptions 329-49 Administrative penalties 329-50 Injunctive relief Part V. Enforcement and Administrative Provisions 329-51 Powers of enforcement personnel 329-52 Administrative inspections 329-53 Injunctions 329-54 Cooperative arrangements and confidentiality 329-55 Forfeitures 329-56 Burden of proof; liabilities 329-57 Judicial review 329-58 Education and research 329-59 Controlled substance registration revolving fund; established Part VI.
    [Show full text]
  • 1 HB2 2 207646-3 3 by Representatives Holmes and Allen 4 RFD: Judiciary 5 First Read: 02-FEB-21 6 PFD: 07/17/2020
    1 HB2 2 207646-3 3 By Representatives Holmes and Allen 4 RFD: Judiciary 5 First Read: 02-FEB-21 6 PFD: 07/17/2020 Page 0 HB2 1 2 ENROLLED, An Act, 3 To amend Section 20-2-25, Code of Alabama 1975, 4 relating to Schedule II of the controlled substances list, to 5 include additional controlled substances; to amend Section 6 20-2-23, Code of Alabama 1975, relating to Schedule I of the 7 controlled substances list, to include additional controlled 8 substances; and in connection therewith would have as its 9 purpose of effect the requirement of a new or increased 10 expenditure of local funds within the meaning of Amendment 621 11 of the Constitution of Alabama of 1901, now appearing as 12 Section 111.05 of the Official Recompilation of the 13 Constitution of Alabama of 1901, as amended. 14 BE IT ENACTED BY THE LEGISLATURE OF ALABAMA: 15 Section 1. Section 20-2-25, Code of Alabama 1975, is 16 amended to read as follows: 17 "§20-2-25. 18 "The controlled substances listed in this section 19 are included in Schedule II: 20 "(1) Any of the following substances, except those 21 narcotic drugs listed in other schedules, whether produced 22 directly or indirectly by extraction from substances of 23 vegetable origin or independently by means of chemical 24 synthesis or by combination of extraction and chemical 25 synthesis: Page 1 HB2 1 "a. Opium and opiate and any salt, compound, 2 derivative, or preparation of opium or opiate. 3 "b.
    [Show full text]
  • House Bill No.11 (2019)
    LEGISLATURE OF THE STATE OF IDAHO Sixty-fifth Legislature First Regular Session - 2019 IN THE HOUSE OF REPRESENTATIVES HOUSE BILL NO. 11 BY HEALTH AND WELFARE COMMITTEE 1 AN ACT 2 RELATING TO CONTROLLED SUBSTANCES; AMENDING SECTION 37-2705, IDAHO CODE, TO 3 REVISE THE LIST OF SCHEDULE I CONTROLLED SUBSTANCES; AMENDING SECTION 4 37-2709, IDAHO CODE, TO PROVIDE AN EXCLUSION AND TO MAKE A TECHNICAL 5 CORRECTION; AMENDING SECTION 37-2713, IDAHO CODE, TO REVISE THE LIST OF 6 SCHEDULE V DRUGS AND SUBSTANCES; AND DECLARING AN EMERGENCY. 7 Be It Enacted by the Legislature of the State of Idaho: 8 SECTION 1. That Section 37-2705, Idaho Code, be, and the same is hereby 9 amended to read as follows: 10 37-2705. SCHEDULE I. (a) The controlled substances listed in this sec- 11 tion are included in schedule I. 12 (b) Any of the following opiates, including their isomers, esters, 13 ethers, salts, and salts of isomers, esters, and ethers, unless specifically 14 excepted, whenever the existence of these isomers, esters, ethers and salts 15 is possible within the specific chemical designation: 16 (1) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-pip- 17 eridinyl]-N-phenylacetamide); 18 (2) Acetylmethadol; 19 (3) Acetyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylac- 20 etamide); 21 (4) Allylprodine; 22 (5) Alphacetylmethadol (except levo-alphacetylmethadol also known as 23 levo-alpha-acetylmethadol, levomethadyl acetate or LAAM); 24 (6) Alphameprodine; 25 (7) Alphamethadol; 26 (8) Alpha-methylfentanyl; 27 (9) Alpha-methylthiofentanyl
    [Show full text]